Home
Search
Search Results
Previously Searched
3199 results found
Expand All
Apply All
3199 results found

Biotech for our Pets
I am BIO Podcast  •  March 26, 2024
More than half of U.S. households include pets, but there has been a lack of medical treatments developed specifically for small animals. Biotech companies are working to change that with new treatment options that both borrow from and, potentially, advance human health discoveries.
Read More
podcast

Heart disease patients and IRA’s misguided incentives
Bio.News  •  March 25, 2024
BIO explains why the Inflation Reduction Act (IRA) price controls will lead to fewer cardiovascular treatments, and how we can achieve the government’s “Bold Goals” for the bioeconomy. (482 words, 2 minutes, 24 seconds)
Read More

Experts call for VICP updates to bolster vaccine confidence
Bio.News  •  March 22, 2024
We recap yesterday’s hearing on the Vaccine Injury Compensation Program (and BIO’s take on reform). Plus, it’s World Water Day—and we look at how biotech can address contamination and demand. (553 words, 2 minutes, 45 seconds)
Read More

Lawmakers urge action on AMR
Bio.News  •  March 21, 2024
Lawmakers and HHS Secretary Xavier Becerra call for action on AMR—and BIO President and CEO John F. Crowley calls for a focus on building America’s biomanufacturing sector. (647 words, 3 minutes, 14 seconds)
Read More

Colorado PDAB could limit patient access to medicines
Bio.News  •  March 20, 2024
We take a deep dive into what’s happening with Colorado’s Prescription Drug Affordability Board (PDAB) and explain why the early cherry blossoms are nothing to cheer (and what biotech could do about it). (501 words, 2 minutes, 30 seconds)
Read More

Pre-Clinical Safety (BioSafe) Committee Meeting
March 19, 2024
The BioSafe General Membership serves as a resource for BIO members and BIO staff by identifying and responding to key scientific and world-wide regulatory issues related to the preclinical safety evaluation of biopharmaceutical products on an as needed basis. General Members can participate in various expert working groups, task forces and work streams related to the preclinical safety of biologics.  For more information and to join the Committee, please contact Surea Gainey (sgainey@bio.org).
Read More

Biden calls for investment in women's health
Bio.News  •  March 19, 2024
We have details on Biden’s EO to boost women’s health research, and BIO’s comments on Mexico’s biotech corn ban. (665 words, 3 minutes, 19 seconds)
Read More

COVID vaccines, four years on
Bio.News  •  March 18, 2024
Saturday was the anniversary of a milestone in the COVID-19 timeline—and a reminder of how the vaccines are a win for health and science. Plus, BIO’s calling for legislation that would boost domestic biomanufacturing. (605 words, 3 minutes, 1 second)
Read More

BIO Comments to HHS on Medicare Prescription Payment Plan: Draft Part Two Guidance on Implementation of Section 1860D-2 of the Social Security Act for 2025
Letters, Testimony & Comments  •  March 16, 2024
The Biotechnology Innovation Organization (BIO) appreciates the opportunity to comment on the Center for Medicare and Medicaid Services’ (CMS’s/the Agency’s) Medicare Prescription Payment Plan: Draft Part Two Guidance on Select Topics, Implementation of Section 1860D-2 of the Social Security Act for 2025, and Solicitation of Comments.
Read More

BIO Request for Information to U.S. House Committee on Education and the Workforce on ERISA’s 50th Anniversary: Reforms to Increase Affordability and Quality in Employer-Sponsored Health Coverage
Letters, Testimony & Comments  •  March 15, 2024
The Biotechnology Innovation Organization (BIO) appreciates the opportunity to comment on the U.S. Committee on Education and the Workforce’s (Committee’s) Request for Information on Reforms to Increase Affordability and Quality in Employer-Sponsored Health Coverage (ERISA RFI).
Read More